| EAU guidelines on penile cancer: 2014 update OW Hakenberg, EM Comperat, S Minhas, A Necchi, C Protzel, N Watkin European urology 67 (1), 142-150, 2015 | 711 | 2015 |
| Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy C Seitz, M Desai, A Häcker, OW Hakenberg, E Liatsikos, U Nagele, ... European urology 61 (1), 146-158, 2012 | 595 | 2012 |
| Assessing the impact of ischaemia time during partial nephrectomy F Becker, H Van Poppel, OW Hakenberg, C Stief, I Gill, G Guazzoni, ... European urology 56 (4), 625-635, 2009 | 580 | 2009 |
| Perioperative complications of radical cystectomy in a contemporary series V Novotny, OW Hakenberg, D Wiessner, U Heberling, RJ Litz, ... European urology 51 (2), 397-402, 2007 | 382 | 2007 |
| Prevention and management of complications following radical cystectomy for bladder cancer N Lawrentschuk, R Colombo, OW Hakenberg, SP Lerner, W Månsson, ... European urology 57 (6), 983-1001, 2010 | 307 | 2010 |
| European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology guidelines … MJ Ribal, P Cornford, A Briganti, T Knoll, S Gravas, M Babjuk, C Harding, ... European urology 78 (1), 21-28, 2020 | 282 | 2020 |
| Lymphadenectomy in the surgical management of penile cancer C Protzel, A Alcaraz, S Horenblas, G Pizzocaro, A Zlotta, OW Hakenberg European urology 55 (5), 1075-1088, 2009 | 269 | 2009 |
| An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer GS Kulkarni, OW Hakenberg, JE Gschwend, G Thalmann, W Kassouf, ... European urology 57 (1), 60-70, 2010 | 262 | 2010 |
| Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement OW Hakenberg, C Linne, A Manseck, MP Wirth Neurourology and Urodynamics: Official Journal of the International …, 2000 | 243 | 2000 |
| Urine markers for detection and surveillance of non–muscle-invasive bladder cancer D Tilki, M Burger, G Dalbagni, HB Grossman, OW Hakenberg, J Palou, ... European urology 60 (3), 484-492, 2011 | 238 | 2011 |
| Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature V Soukup, M Babjuk, J Bellmunt, G Dalbagni, G Giannarini, ... European urology 62 (2), 290-302, 2012 | 180 | 2012 |
| Laparoscopic living-donor nephrectomy: analysis of the existing literature F Greco, MR Hoda, A Alcaraz, A Bachmann, OW Hakenberg, P Fornara European urology 58 (4), 498-509, 2010 | 178 | 2010 |
| The diagnosis and treatment of penile cancer OW Hakenberg, DL Dräger, A Erbersdobler, CM Naumann, KP Jünemann, ... Deutsches Ärzteblatt International 115 (39), 646, 2018 | 175 | 2018 |
| Vaccination of hormone‐refractory prostate cancer patients with peptide cocktail‐loaded dendritic cells: Results of a phase I clinical trial S Fuessel, A Meye, M Schmitz, S Zastrow, C Linné, K Richter, B Löbel, ... The Prostate 66 (8), 811-821, 2006 | 158 | 2006 |
| Antiandrogens in the treatment of prostate cancer MP Wirth, OW Hakenberg, M Froehner European urology 51 (2), 306-314, 2007 | 142 | 2007 |
| The estimation of bladder volume by sonocystography OW Hakenberg, RL Ryall, SL Langlois, VR Marshall The Journal of urology 130 (2), 249-251, 1983 | 135 | 1983 |
| Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma S Schrödter, OW Hakenberg, A Manseck, S Leike, MP Wirth The Journal of urology 167 (4), 1630-1633, 2002 | 133 | 2002 |
| Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients … M Guba, J Pratschke, C Hugo, BK Krämer, C Nohr-Westphal, ... Transplantation 90 (2), 175-183, 2010 | 130 | 2010 |
| Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma OW Hakenberg, JBW Nippgen, M Froehner, S Zastrow, MP Wirth BJU international 98 (6), 1225-1227, 2006 | 126 | 2006 |
| Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA S Fuessel, J Herrmann, S Ning, M Kotzsch, K Kraemer, U Schmidt, ... Cancer letters 232 (2), 243-254, 2006 | 110 | 2006 |
